Floatz logo

nb02

Primary CNS Lymphoma (PCNSL)

NOBO MedicinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Primary CNS Lymphoma (PCNSL) cohort.

Asset / SponsorPhaseRating
Teniposide
Huashan Hospital
Phase 4BB
Fotemustine
Mingzhi Zhang
Phase 4BB
Epcoritamab
The Lymphoma Academic Research Organisation
Phase 2B
Anbalcabtagene Autoleucel
Hyungwoo Cho
Phase 2CCC
Benadryl
Hyungwoo Cho
Phase 2CCC

Same molecule, other indications

nb02 is also rated in:

Non Hodgkin Lymphoma (NHL)Dormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →